在P. falciparum中调解药物耐受性的oleuropein诱导自的协议
Sonia Devi1, Sushmita Negi1, Prakriti Sharma2
1Division of Cell Biology and Immunology, Biomedical Parasitology and Translational-immunology Lab, CSIR-Institute of Microbial Technology (IMTECH), Sec-39A, Chandigarh 160036, India; Academy of Scientific and Innovation Research (AcSIR), Ghaziabad 201002, India.
这项研究详细介绍了在体外培养Plasmodium falciparum (疟疾寄生虫) 的协议. 它可以测试药物敏感性,并探索寄生虫自和药物耐受性机制.
科学领域:
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 巨细胞炎症模型突出显示了PI3K-Akt1在免疫恒温中发出信号.
- 植物化合物,如欧蛋白 (OLP) 显示抗炎作用的潜力.
- 了解寄生虫的耐药性对于疟疾治疗至关重要.
研究的目的:
- 提出一个详细的规程,用于培养Plasmodium falciparum的体外培养.
- 为了使药物敏感性测试能够用于抗疟疾药物的开发.
- 研究寄生虫自和药物耐受性机制.
主要方法:
- 寄生虫同步技术.寄生虫同步技术.
- 标准化药物治疗方案.
- DNA隔离和饥饿诱导的自分析.
主要成果:
- 建立了P. falciparum体外培养的可复制协议.
- 该协议促进了药物敏感性测试.
- 获得了对寄生虫自和耐药压力的洞察力.
结论:
- 提出的协议对抗疟疾研究有价值.
- 它有助于理解在药物压力下寄生虫生存机制.
- 进一步的研究可以建立在这种新药发现方法的基础上.
更多相关视频
10:22Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmaceutical Poisoning: Treatment Strategies
Anthelminthic Agents
